Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR) - SOLAR
Study identifier:4522US/0003
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A 12-week, Randomized, Open-Label, 3 Arm Parallel group, Multicenter, Phase IIIb Study comparing the efficacy and safety of Rosuvastatin with Atorvastatin and Simvastatin Achieving NCEP ATP III LDL-C Goals in high risk subjects with Hypercholesterolaemia in the Managed Care Setting.
Medical condition
Hypercholesterolemia
Phase
Phase 3
Healthy volunteers
No
Study drug
Rosuvastatin, Simvastatin, Atorvastatin
Sex
All
Actual Enrollment
4444
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Jun 2002
Primary Completion Date: -
Study Completion Date: 01 Sept 2004
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 Rosuvastatin | - |
| Active Comparator: 2 Simvastatin | - |
| Active Comparator: 3 Atorvastatin | - |
Contacts
Investigators
Principal Investigator
Alex Gold
Astra Zeneca
